PHARMACEUTICAL COMPOSITIONS CONTAINING IMIDAZOTHIADIAZOLE AND IMIDAZOPYRAZINE DERIVATIVES AS INHIBITORS OF PROTEASE-ACTIVATED RECEPTOR 4 (PAR4) FOR TREATING PLATELET AGGREGATION
CY1125779T1Undetermined Publication Date: 2026-04-17UNIV DE MONTREAL
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CY20231100005T
- Authority / Receiving Office
- CY · CY
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2013-03-15
- Filing Date
- 2023-01-04
- Publication Date
- 2026-04-17
- Estimated Expiration
- 2043-01-04
Abstract
The present invention provides pharmaceutical compositions comprising an imidazothiadiazole or imidazopyridazine compound that is a PAR4 antagonist, a pharmaceutically acceptable carrier and another therapeutic agent.
Need to check novelty before this filing date? Find Prior Art